{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:02:26Z","timestamp":1791590546775,"version":"4.3.4"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1097\/fpc.0b013e32833f2cd0","type":"journal-article","created":{"date-parts":[[2010,9,8]],"date-time":"2010-09-08T07:05:28Z","timestamp":1283929528000},"page":"665-676","source":"Crossref","is-referenced-by-count":51,"title":["Generation of novel pharmacogenomic candidates in response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype"],"prefix":"10.1097","volume":"20","author":[{"given":"Halima","family":"Moncrieffe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Hinks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ursu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kassoumeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Etheridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Hubank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Weiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan D.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy R.","family":"Wedderburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210214","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/adc.88.3.197","article-title":"Use of methotrexate in juvenile idiopathic arthritis","volume":"88","author":"Ramanan","year":"2003","journal-title":"Arch Dis Child"},{"key":"R2-2-20210214","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/rheumatology\/kem279","article-title":"Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis","volume":"47","author":"Wessels","year":"2008","journal-title":"Rheumatology"},{"key":"R3-2-20210214","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/1529-0131(200008)43:8<1849::AID-ANR22>3.0.CO;2-F","article-title":"Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis","volume":"43","author":"Woo","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R4-2-20210214","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/art.20288","article-title":"A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate","volume":"50","author":"Ruperto","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R5-2-20210214","article-title":"Kelley's textbook of Rheumatology","author":"Nistala","year":"2009"},{"key":"R6-2-20210214","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/ard.2007.075895","article-title":"Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis","volume":"67","author":"Cespedes-Cruz","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R7-2-20210214","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/art.10863","article-title":"Outcome in adults with juvenile idiopathic arthritis: a quality of life study","volume":"48","author":"Foster","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R8-2-20210214","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.rdc.2007.07.003","article-title":"Measurement of health status, functional status, and quality of life in children with juvenile idiopathic arthritis: clinical science for the pediatrician","volume":"33","author":"Duffy","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"R9-2-20210214","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0049-0172(98)80049-8","article-title":"Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity","volume":"27","author":"Van Ede","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"R10-2-20210214","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/art.21762","article-title":"Methotrexate pharmacogenetics: the first step toward individualized therapy in rheumatoid arthritis","volume":"54","author":"Ranganathan","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R11-2-20210214","first-page":"6","article-title":"Mechanisms of the effects of methotrexate","volume":"45","author":"Cronstein","year":"1996","journal-title":"Bull Rheum Dis"},{"key":"R12-2-20210214","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/1529-0131(200107)44:7<1515::AID-ART273>3.0.CO;2-7","article-title":"Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study","volume":"44","author":"Van Ede","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R13-2-20210214","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/art.21726","article-title":"Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes","volume":"54","author":"Wessels","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R14-2-20210214","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/ard.62.1.4","article-title":"Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis?","volume":"62","author":"Ranganathan","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R15-2-20210214","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/rheumatology\/ken182","article-title":"Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX","volume":"47","author":"Hider","year":"2008","journal-title":"Rheumatology"},{"key":"R16-2-20210214","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/art.22640","article-title":"A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis","volume":"56","author":"Wessels","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R17-2-20210214","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1365-2125.2005.02445.x","article-title":"How children's responses to drugs differ from adults","volume":"59","author":"Stephenson","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"R18-2-20210214","first-page":"1832","article-title":"Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis","volume":"32","author":"Schmeling","year":"2005","journal-title":"J Rheumatol"},{"key":"R19-2-20210214","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/art.24087","article-title":"Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis","volume":"61","author":"Albers","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R20-2-20210214","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"R21-2-20210214","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","article-title":"Preliminary definition of improvement in juvenile arthritis","volume":"40","author":"Giannini","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R22-2-20210214","first-page":"S163","article-title":"The British version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ)","volume":"19","author":"Nugent","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"R23-2-20210214","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/art.24534","article-title":"Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets","volume":"60","author":"Griffin","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R24-2-20210214","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/art.24601","article-title":"Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis","volume":"60","author":"Barnes","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R25-2-20210214","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"R26-2-20210214","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"R27-2-20210214","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/ard.2007.073445","article-title":"The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis","volume":"67","author":"Bartoli","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R28-2-20210214","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1002\/art.20460","article-title":"Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis","volume":"50","author":"Dervieux","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R29-2-20210214","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/art.21573","article-title":"Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis","volume":"54","author":"Weisman","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R30-2-20210214","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1600-065X.2008.00650.x","article-title":"Regulation of T-cell responses by PTEN","volume":"224","author":"Buckler","year":"2008","journal-title":"Immunol Rev"},{"key":"R31-2-20210214","doi-asserted-by":"crossref","first-page":"7797","DOI":"10.1073\/pnas.0800928105","article-title":"T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR","volume":"105","author":"Sauer","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R32-2-20210214","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1101\/gad.1452206","article-title":"Deficiency of Rbbp1\/Arid4a and Rbbp1l1\/Arid4b alters epigenetic modifications and suppresses an imprinting defect in the PWS\/AS domain","volume":"20","author":"Wu","year":"2006","journal-title":"Genes Dev"},{"key":"R33-2-20210214","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/gcc.20437","article-title":"DNA sequence of the translocation breakpoints in undifferentiated embryonal sarcoma arising in mesenchymal hamartoma of the liver harboring the t(11;19)(q11;q13.4) translocation","volume":"46","author":"Rajaram","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"R34-2-20210214","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1471-2164-10-163","article-title":"A transcriptional sketch of a primary human breast cancer by 454 deep sequencing","volume":"10","author":"Guffanti","year":"2009","journal-title":"BMC Genomics"},{"key":"R35-2-20210214","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/ijc.11135","article-title":"Identification of drug-regulated genes in osteosarcoma cells","volume":"105","author":"Fellenberg","year":"2003","journal-title":"Int J Cancer"},{"key":"R36-2-20210214","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2350-10-6","article-title":"An open access database of genome-wide association results","volume":"10","author":"Johnson","year":"2009","journal-title":"BMC Med Genet"},{"key":"R37-2-20210214","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00296-007-0339-0","article-title":"Transcription regulatory polymorphism -43T>C in the 5\u2032-flanking region of SLC19A1 gene could affect rheumatoid arthritis patient response to methotrexate therapy","volume":"27","author":"Chatzikyriakidou","year":"2007","journal-title":"Rheumatol Int"},{"key":"R38-2-20210214","first-page":"562","article-title":"Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis","volume":"35","author":"James","year":"2008","journal-title":"J Rheumatol"},{"key":"R39-2-20210214","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1093\/emboj\/cdg226","article-title":"Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins","volume":"22","author":"Postigo","year":"2003","journal-title":"Embo J"},{"key":"R40-2-20210214","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1126\/science.1840704","article-title":"Identification of a zinc finger protein that inhibits IL-2 gene expression","volume":"254","author":"Williams","year":"1991","journal-title":"Science"},{"key":"R41-2-20210214","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/art.20043","article-title":"Additional genetic susceptibility for rheumatoid arthritis telomeric of the DRB1 locus","volume":"50","author":"Kilding","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R42-2-20210214","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1365-2443.2001.00435.x","article-title":"The central MHC gene, BAT1, may encode a protein that down-regulates cytokine production","volume":"6","author":"Allcock","year":"2001","journal-title":"Genes Cells"},{"key":"R43-2-20210214","first-page":"741","article-title":"BAT1 promoter polymorphism is associated with rheumatoid arthritis susceptibility","volume":"35","author":"Quinones-Lombrana","year":"2008","journal-title":"J Rheumatol"},{"key":"R44-2-20210214","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1084\/jem.194.1.89","article-title":"Tumor necrosis factor receptor-associated factor (TRAF)2 represses the T helper cell type 2 response through interaction with NFAT-interacting protein (NIP45)","volume":"194","author":"Lieberson","year":"2001","journal-title":"J Exp Med"},{"key":"R45-2-20210214","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.molcel.2004.06.042","article-title":"Arginine methylation of NIP45 modulates cytokine gene expression in effector T lymphocytes","volume":"15","author":"Mowen","year":"2004","journal-title":"Mol Cell"},{"key":"R46-2-20210214","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/ng2142","article-title":"Population genomics of human gene expression","volume":"39","author":"Stranger","year":"2007","journal-title":"Nat Genet"},{"key":"R47-2-20210214","doi-asserted-by":"crossref","first-page":"R170","DOI":"10.1186\/gb-2008-9-12-r170","article-title":"FitSNPs: highly differentially expressed genes are more likely to have variants associated with disease","volume":"9","author":"Chen","year":"2008","journal-title":"Genome Biol"},{"key":"R48-2-20210214","doi-asserted-by":"crossref","first-page":"e6511","DOI":"10.1371\/journal.pone.0006511","article-title":"GWAS meets microarray: are the results of genome-wide association studies and gene-expression profiling consistent? Prostate cancer as an example","volume":"4","author":"Gorlov","year":"2009","journal-title":"PLoS One"},{"key":"R49-2-20210214","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/FPC.0b013e3282fe1745","article-title":"Identification of genetic variants and gene expression relationships associated with pharmacogenes in humans","volume":"18","author":"Huang","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"R50-2-20210214","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1371\/journal.pmed.0050083","article-title":"In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile","volume":"5","author":"Sorich","year":"2008","journal-title":"PLoS Med"},{"key":"R51-2-20210214","first-page":"2521","article-title":"PTEN inhibits IL-2 receptor-mediated expansion of CD4+ CD25+ Tregs","volume":"116","author":"Walsh","year":"2006","journal-title":"J Clin Invest"},{"key":"R52-2-20210214","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.4049\/jimmunol.177.7.4262","article-title":"Cutting edge: T cell requirement for CD28 costimulation is due to negative regulation of TCR signals by PTEN","volume":"177","author":"Buckler","year":"2006","journal-title":"J Immunol"},{"key":"R53-2-20210214","first-page":"1817","article-title":"Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate","volume":"34","author":"Parker","year":"2007","journal-title":"J Rheumatol"},{"key":"R54-2-20210214","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1677\/joe.0.1690453","article-title":"Peroxisome proliferator-activated receptors in inflammation control","volume":"169","author":"Delerive","year":"2001","journal-title":"J Endocrinol"},{"key":"R55-2-20210214","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1530\/REP-09-0038","article-title":"Glucose deprivation, oxidative stress and peroxisome proliferator-activated receptor-alpha (PPARA) cause peroxisome proliferation in preimplantation mouse embryos","volume":"138","author":"Jansen","year":"2009","journal-title":"Reproduction"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FPC.0b013e32833f2cd0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:37:55Z","timestamp":1786041475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01213011-201011000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0b013e32833f2cd0","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}